Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - LONG-TERM DEBT
Long-term Debt NVO - Novo Nordisk A/S
20.5 B
LAST VALUE
25.85%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR